X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results   (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m37,57839,89039,67937,56232,22536,16337,23236,119 
Other income Rs m125320122307670438403205 
Turnover Rs m37,70340,21039,80137,86932,89536,60137,63536,324 
Expenses Rs m38,03630,95232,22332,79728,32329,89328,58730,214 
Gross profit Rs m7,4628,6187,5844,8243,9756,3558,7346,007 
Depreciation Rs m00002,4362,6222,6652,543 
Interest Rs m-216216622,646148126164196 
Profit before tax Rs m7,8038,7227,6442,4852,0614,0456,3083,473 
Tax Rs m1,7211,8791,7881,7395269561,38597 
Profit after tax Rs m6,0826,8435,8567461,5353,0894,9233,376 
Gross profit margin %19.921.619.112.812.317.623.516.6 
Effective tax rate %22.121.523.470.025.523.622.02.8 
Net profit margin %16.217.214.82.04.88.513.29.3 
Diluted EPS Rs 36.7 41.3 35.3 4.5 9.3 18.6 29.7 20.4  
Diluted EPS (TTM) Rs 136.8 143.7 144.4 117.8 90.4 67.7 62.1 78.0  
 Subscriber Feature View View     View        
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   FRESENIUS KABI ONCO.  DISHMAN PHARMA  ALEMBIC LTD  IPCA LABS  DIVIS LABORATORIES  

Compare DR. REDDYS LAB With:   FRESENIUS KABI ONCO.  DISHMAN PHARMA  ALEMBIC LTD  IPCA LABS  DIVIS LABORATORIES  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Erase Gains; Telecom Stocks Plunge as RIL Unveils JioPhone(01:30 pm)

After opening the day marginally higher, the share markets in India are currently trading below the dotted line. Sectoral indices are trading mixed with stocks in the information technology sector.

Views on news

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

Warren Buffett's Long Term Returns Immune to Volatility(Chart Of The Day)

Jul 8, 2017

Buffett's periodic underperformance to index fund.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 21, 2017 03:37 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - PLETHICO PHARMA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS